In children ages 6 to 12 years who took Vyvanse every day for a year in clinical trials, weight loss led to slowed growth
(Genome Medicine, March 2026) with 1,119 participants, non-carriers hit HbA1c targets at 25 percent, p.S539W carriers at 11.5 percent, and p.D563G at 18.5 percent
Martin uses Ozempic herself: I was the first K Health patient who started on Ozempic, she recalls
Slower titration significantly reduces both the severity and duration of these side effects
The Phase 2 and Phase 3 trials so far have shown a safety profile broadly consistent with other GLP-1 medications: gastrointestinal side effects are common, and a new signal called dysaesthesia (an abnormal skin sensation) appears more often at higher doses
9,10 Another emerging concern is the potential loss of lean muscle mass